{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:08:36Z","timestamp":1793236116930,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The purpose of this study is to investigate whether aspirin improves the prognosis of breast cancer patients by meta analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Searched PubMed, EMBASE, and other databases for literature on the relationship between aspirin use and breast cancer prognosis, with the deadline of October 2019. The related results of all-cause death, breast cancer-specific death, and breast cancer recurrence\/metastasis were extracted to combine the effect amount. The sensitivity analysis and published bias analysis were carried out for the included data. Stata12.0 software was used to complete all statistical analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 13 papers were included in the study, including 142,644 breast cancer patients. The results of meta-analysis showed that patients who took aspirin were associated with lower breast cancer-specific death (HR\u200a=\u200a0.69, 95% CI\u200a=\u200a0.61\u20130.76), all-cause death (HR\u200a=\u200a0.78, 95% CI\u200a=\u200a0.71\u20130.84), and risk of recurrence\/metastasis (HR\u200a=\u200a0.91, 95% CI: 0.82\u20131.00).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Aspirin use may improve all-cause mortality, specific mortality, and risk of recurrence\/metastasis in patients with breast cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026870","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T13:05:44Z","timestamp":1629464744000},"page":"e26870","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Effect of aspirin use on survival benefits of breast cancer patients"],"prefix":"10.1097","volume":"100","author":[{"given":"Jiamin","family":"Liu","sequence":"first","affiliation":[{"name":"College of Medicine, Guangxi University of Traditional Chinese Medicine, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxian","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Affiliated Danzhou People's Hospital of Hainan Medical University, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Affiliated Danzhou People's Hospital of Hainan Medical University, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Basic Nursing, School of Nursing, Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1002\/cam4.2654","article-title":"Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: a prospective randomized controlled trial","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2018","journal-title":"Int J Cancer"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends\u2014an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.7150\/jca.32435","article-title":"Racial disparities in young-onset patients with colorectal, breast and testicular cancer","volume":"10","author":"Wu","year":"2019","journal-title":"J Cancer"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"549","DOI":"10.26444\/aaem\/75943","article-title":"Primary and secondary prevention of breast cancer","volume":"24","author":"Kolak","year":"2006","journal-title":"Ann Agric Environ Med"},{"key":"R6-20250504","first-page":"526","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study","volume":"105","author":"Day","year":"2013","journal-title":"Breast Diseases: A Year Book Quarterly"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s12885-015-1098-z","article-title":"Residential environment and breast cancer incidence and mortality: a systematic review and meta-analysis","volume":"15","author":"Akinyemiju","year":"2015","journal-title":"BMC Cancer"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1007\/s10549-014-2852-7","article-title":"Reproductive risk factors and breast cancer subtypes: a review of the literature","volume":"144","author":"Anderson","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/pds.4870","article-title":"Reduced risk of cancer among low-dose aspirin users: data from French health care databases","volume":"28","author":"Ajrouche","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1002\/cam4.2277","article-title":"Prevention of gastric cancer by Helicobacter pylori eradication: a review from Japan","volume":"8","author":"Uno","year":"2019","journal-title":"Cancer Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/bjc.2014.264","article-title":"Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study","volume":"111","author":"Fraser","year":"2014","journal-title":"Br J Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10552-018-1020-5","article-title":"Pre-diagnostic aspirin use and mortality after breast cancer","volume":"29","author":"Wang","year":"2018","journal-title":"Cancer Causes Control"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/bjoc.2000.1119","article-title":"Nested case\u2013control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage","volume":"83","author":"Sharpe","year":"2000","journal-title":"Br J Cancer"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/HCO.0b013e3283570040","article-title":"Personalizing cardiovascular disease prevention among breast cancer survivors","volume":"27","author":"Singla","year":"2012","journal-title":"Curr Opin Cardiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2013.03.003","article-title":"Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers","volume":"66","author":"Hartling","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-006-9277-x","article-title":"NSAID use and survival after breast cancer diagnosis in post-menopausal women","volume":"101","author":"Blair","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/pds.2064","article-title":"Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors","volume":"20","author":"Wernli","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1158\/0008-5472.CAN-13-2679","article-title":"Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study","volume":"74","author":"Barron","year":"2014","journal-title":"Cancer Res"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/1055-9965.EPI-14-1415","article-title":"De Novo post-diagnosis aspirin use and mortality in women with Stage I-III breast cancer","volume":"24","author":"Barron","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10549-016-4081-8","article-title":"Aspirin\/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients","volume":"161","author":"Shiao","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1002\/cncr.32364","article-title":"Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: a population-based study","volume":"125","author":"Wang","year":"2019","journal-title":"Cancer"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13058-018-1065-0","article-title":"No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study","volume":"20","author":"Frisk","year":"2018","journal-title":"Breast Cancer Res"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/EDE.0000000000000480","article-title":"Low-dose aspirin, nonsteroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence","volume":"27","author":"Cronin-Fenton","year":"2016","journal-title":"Epidemiology"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ypmed.2018.09.015","article-title":"Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study","volume":"116","author":"Bens","year":"2018","journal-title":"Prev Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","article-title":"Aspirin intake and survival after breast cancer","volume":"28","author":"Holmes","year":"2010","journal-title":"J Clin Oncol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"6380643","DOI":"10.1155\/2018\/6380643","article-title":"Aspirin disrupts the crosstalk of angiogenic and inflammatory cytokines between 4T1 breast cancer cells and macrophages","volume":"2018","author":"Hsieh","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10911-015-9333-4","article-title":"New Insights on COX-2 in chronic inflammation driving breast cancer growth and metastasis","volume":"20","author":"Hugo","year":"2015","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Myriam","year":"2011","journal-title":"Cancer Cell"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1471-2407-14-391","article-title":"Aspirin intake and breast cancer survival \u2013 a nation-wide study using prospectively recorded data in Sweden","volume":"14","author":"Holmes","year":"2014","journal-title":"BMC Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:00:42Z","timestamp":1746345642000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026870"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":29,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026870","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"assertion":[{"value":"2019-12-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}